CE Certified hyaluronic acid dermal filler (medical device) from CHA Meditech.
Manufactured under medical device quality management systems and Good Manufacturing Practice.
Uses V Phasic technology with low residual BDDE levels, as highlighted in brand technical literature.
Designed and tested to meet safety and performance requirements for injectable HA fillers in its regulatory markets.
CE Certified hyaluronic acid dermal filler (medical device) from CHA Meditech.
Manufactured under medical device quality management systems and Good Manufacturing Practice.
Uses V Phasic technology with low residual BDDE levels, as highlighted in brand technical literature.
Designed and tested to meet safety and performance requirements for injectable HA fillers in its regulatory markets.
Facial contouring hyaluronic acid dermal filler
Description
Hyafilia V Plus is a CE-certified, V-phasic hyaluronic acid dermal filler from CHA Meditech designed to restore facial volume and create a natural V-line. Produced from ultra-pure, cross-linked hyaluronic acid with lidocaine, it offers deep, natural hydration and long-lasting volumisation while stimulating fibroblasts to support collagen production. Its V-phasic technology combines the advantages of bi-phasic and mono-phasic fillers, providing high cohesiveness and elasticity with a low injection force for smooth, precise injections and natural-looking results.
Bnefits
V-phasic technology combines the best properties of bi-phasic and mono-phasic fillers, providing both cohesiveness and elasticity.
Deep, natural hydration of the skin with ultra-pure cross-linked hyaluronic acid.
Restores facial volume and supports a defined, natural V-line facial contour.
High cohesiveness helps maintain shape and reduces risk of product migration after injection.
Low injection force allows smooth, controlled injections and may reduce patient discomfort and immediate tissue trauma.
Lidocaine content improves patient comfort during the procedure.
Long-lasting volumising effect, with results typically maintained for around 12 months or more in many patients.
CE-certified medical device manufactured with specialised Korean filler technology and low residual BDDE.
Indications
Temporary improvement of facial wrinkles and folds in adults by restoring volume with cross-linked hyaluronic acid.
Volumisation and contouring of the mid and lower face, particularly to support a natural V-line.
Treatment of deep lines and wrinkles such as nasolabial folds.
Augmentation and contouring of areas including chin, jawline and cheeks, as per professional indication.
General facial volumisation where a cohesive, elastic HA filler is clinically appropriate.
Cross-linked hyaluronic acid 20 mg/ml (main active ingredient).
Lidocaine 0.3% for local anaesthetic effect and improved injection comfort.
BDDE (cross-linking agent) not detected in final product, according to distributor specifications.
Additional excipients as per manufacturer’s instructions for use (buffer, water for injection, etc.).
Formulation
V-phasic hyaluronic acid gel combining structural properties of bi-phasic and mono-phasic fillers.
Ultra-pure, cross-linked HA dermal filler with high cohesiveness and elasticity.
Sterile, pyrogen-free, viscoelastic gel intended for injection into facial soft tissues.
Medical device type: Class III CE-certified injectable implant for temporary wrinkle improvement.
Unit volume: 1 ml pre-filled syringe.
Packaging
Box containing 1 x 1 ml pre-filled sterile syringe of Hyafilia V Plus.
Typically supplied with 1 x 25G premium thin-walled needle and 1 x 27G premium thin-walled needle (per Dermadirect and similar listings).
Single-use medical device; syringe and needles must not be resterilised or reused.
Syringe and needles presented in a sterile blister within an outer carton.
Usage
Hyafilia V Plus must only be administered by trained and appropriately qualified healthcare professionals experienced in dermal filler injections.
Carry out a full medical history and facial assessment, discuss expectations and obtain informed consent before treatment.
Clean and disinfect the treatment area using an appropriate antiseptic and maintain strict aseptic technique throughout the procedure.
Attach the supplied 25G or 27G sterile needle (or other suitable needle/cannula according to clinical judgement) to the syringe, expel air and check for free flow of the gel.
Inject into the appropriate tissue plane (typically mid-to-deep dermis or subcutaneous plane, depending on indication and area) using linear threading, fanning or serial puncture techniques, avoiding intravascular injection.
Adjust injection depth, volume and technique to the specific area being treated (e.g. nasolabial folds, chin, jawline) and to the patient’s anatomy to achieve a balanced, natural V-line contour.
Inject slowly with minimal pressure, taking advantage of the low injection force design to maintain control and reduce trauma.
After injection, gently mould or smooth the treated area as needed to ensure even distribution and a natural contour.
Provide post-treatment advice, including avoiding excessive heat or cold, vigorous exercise, alcohol and manipulation or massage of the treated area for a period recommended by the practitioner.
Schedule follow-up review to assess results, manage any adverse events and plan maintenance treatment if required.
Dispose of used syringe and needles immediately after use in approved sharps containers; any remaining product must be discarded and not reused.
Contraindications
Known hypersensitivity or allergy to hyaluronic acid, lidocaine or any component of the product.
History of severe allergic reactions or anaphylaxis.
Presence of active infection, inflammation or skin disease at or near the intended injection site.
Autoimmune disease or immune system disorders in which the treating physician considers HA fillers inappropriate.
Tendency to develop hypertrophic scars or keloids in the proposed treatment area.
Pregnancy or breastfeeding (use not recommended due to insufficient safety data).
Patients under 18 years of age.
Injection into blood vessels or intramuscular planes, or use in anatomical areas not specified in the manufacturer’s instructions for use.
Use in patients with known sensitivity to local anaesthetics of the amide type (because of lidocaine content) unless the clinician deems its use acceptable.
Adverse Effects
Common, usually transient injection-site reactions such as redness, swelling, tenderness, pain, itching, bruising or haematoma.
Temporary lumps, nodules or irregularities that may resolve spontaneously or with gentle massage and appropriate clinical management.
Transient asymmetry or overcorrection requiring clinical review or adjustment at follow-up.
Localised inflammatory or hypersensitivity reactions, including prolonged swelling or induration, which may require medical treatment.
Potential infection at the injection site if aseptic technique is not strictly followed or if post-procedure care is inadequate.
Rare but serious complications associated with intravascular injection, including vascular occlusion, tissue ischaemia or necrosis, and in very rare cases visual disturbance or blindness if injected into or near critical vessels.
Systemic effects related to lidocaine (e.g. CNS or cardiovascular symptoms) are rare at typical doses but may occur in case of overdose or intravascular injection.
Storage Conditions
Store in the original blister and outer carton to maintain sterility and protect from light.
Recommended storage temperature generally 1–30 °C or 2–25 °C in a dry place, as specified by manufacturer; do not freeze.
Protect from excessive heat and direct sunlight.
Do not use after the expiry date printed on the packaging.
Do not use if the blister, syringe or packaging is damaged, opened or if sterility is in doubt.
Duration
Clinical and distributor information indicates that results from Hyafilia V Plus generally last around 6\u201312 months, with many sources reporting typical durations of approximately 12 months or longer depending on area treated, injection technique, individual metabolism and lifestyle factors.
Onset
Volume restoration and contour improvement are visible immediately after injection, with the final aesthetic result stabilising over the following days to weeks as transient swelling subsides and the gel integrates into the surrounding tissues.
